BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20939674)

  • 1. Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
    Hu Y; Wu YY; Xia XJ; Wu Z; Liang WQ; Gao JQ
    Drug Deliv; 2011 Jan; 18(1):84-9. PubMed ID: 20939674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on alpha-asarone reservoir-type patch].
    Wu Z; Gao JQ; Chen HL; Hu Y; Liang WQ
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(6):484-7. PubMed ID: 17552150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
    Liu J; Wang Z; Liu C; Xi H; Li C; Chen Y; Sun L; Mu L; Fang L
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1008-14. PubMed ID: 22126709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system.
    Park CW; Son DD; Kim JY; Oh TO; Ha JM; Rhee YS; Park ES
    Int J Pharm; 2012 Oct; 436(1-2):32-40. PubMed ID: 22771734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
    Cui H; Quan P; Zhou Z; Fang L
    Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of α-asarone transdermal patches based on hot-melt pressure-sensitive adhesives.
    Yu Z; Liang Y; Liang W
    AAPS PharmSciTech; 2013 Mar; 14(1):294-300. PubMed ID: 23307595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Prolonged-Release Pramipexole Transdermal Patch: In Vitro and In Vivo Evaluation.
    Pu T; Li X; Sun Y; Ding X; Pan Y; Wang Q
    AAPS PharmSciTech; 2017 Apr; 18(3):738-748. PubMed ID: 27245330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G; Dhawan S; HariKumar SL
    Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of permeation enhancers on dynamic mechanical properties of acrylate pressure sensitive adhesives.
    Khire A; Vavia P
    Int J Pharm; 2013 Dec; 458(1):141-7. PubMed ID: 24120455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the effect of deep eutectic formation on drug-polymer miscibility and skin permeability of rotigotine drug-in-adhesive patch.
    Liu C; Qu X; Song L; Shang R; Wan X; Fang L
    Int J Pharm; 2020 Jan; 574():118852. PubMed ID: 31759103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug in Adhesive Patch of Zolmitriptan: Formulation and In vitro /In vivo Correlation.
    Liu C; Fang L
    AAPS PharmSciTech; 2015 Dec; 16(6):1245-53. PubMed ID: 25771739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
    Roy SD; Gutierrez M; Flynn GL; Cleary GW
    J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of transdermal therapeutic formulation of CNS5161, a novel NMDA receptor antagonist, by utilizing pressure-sensitive adhesives II: improved transdermal absorption and evaluation of efficacy and safety.
    Naruse M; Ogawara K; Kimura T; Konishi R; Higaki K
    Eur J Pharm Sci; 2014 Feb; 52():86-94. PubMed ID: 24215737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
    Vora D; Banga AK
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
    Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
    Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.